Posted on May 27, 2008 by Joel Shpigel R.Ph.

New Drug for Type 2 Diabetes Coming Soon

 Novo Nordisk has submitted a new drug application to the FDA in the U.S., for the approval of liraglutide, a once-daily human GLP-1 analogue, for the treatment of people with type 2 diabetes.

Tags: , , , , ,
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.diabetespharmacist.com/admin/trackback/72864
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.